ASHP to Testify at House Hearing on Compounding

Published Online: Tuesday, July 16, 2013
PRESS RELEASE

July 16, 2013--ASHP is scheduled to testify today at a congressional hearing on reforming the regulatory framework of pharmacy compounding.
 
Kasey K. Thompson, Pharm.D.,  M.S., ASHP vice president of policy, planning, and communications, will represent the Society at the hearing called by the Health Subcommittee of the House Energy and Commerce Committee.
 
ASHP members are encouraged to email their House of Representatives member and ask for support of compounding legislation that establishes a clear jurisdictional boundary between the FDA and state boards of pharmacy.
 
The hearing will be broadcast at 3:00 p.m. on the Committee's website.
Latest Articles
OTC medications can have serious side effects in children if they are not carefully administered.
Patients with asthma can now access Spiriva Respimat with a prescription at pharmacies across the country.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
Latest Issues
$auto_registration$